Table 2.
Clinical features | Laboratory features | Electrodiagnostic | Treatment | |
---|---|---|---|---|
Multifocal motor neuropathy | ||||
Asymmetric, distal > proximal, upper limb > lower limb weakness without sensory loss. Some patients with subjective sensory loss, pain, and fatigue | CSF protein usually normal 40%–50% of patients may have IgM ganglioside antibodies43 | Multifocal demyelinating motor neuropathy with or without conduction block | IVIg, rituximab, and cyclophosphamide Does not respond to steroids or plasma exchange | |
Disorder | Overlapping features | Distinctive clinical features | Diagnostic features: laboratory and EDx | Treatment |
| ||||
Neuromuscular disorders with similar clinical and electrodiagnostic features | ||||
Multifocal acquired demyelinating sensory and motor neuropathy (MADSAM) | Asymmetric, distal > proximal, upper limb > lower limb involvement | Prominent sensory loss | CSF protein usually elevated with no pleocytosis EDx: Multifocal demyelinating sensory and motor neuropathy with conduction block |
Steroids, IVIg, and plasma exchange Others include: azathioprine, cyclosporine, cyclophosphamide, and methotrexate |
Multifocal acquired motor axonopathy (MAMA) | Asymmetric, distal > proximal weakness without sensory loss | Normal CSF studies EDx: Multifocal axonal motor neuropathy in the distribution of individual nerves with no demyelination or conduction block (closely mimics motor neuron disease) |
IVIg? Close observation for signs of motor neuron disease |
|
Hereditary neuropathy with predisposition to pressure palsy (HNPP) | Asymmetric weakness in the distribution of multiple named nerves, typically at common entrapment sites | Sensory loss, may have family history (autosomal dominant) | Genetic testing for PMP22 deletion EDx: Focal neuropathies at common sites of entrapment (may have underlying demyelinating neuropathy and occasionally closely mimics CIDP) |
Supportive, avoid positioning/postures that lead to compression of susceptible nerves |
Motor neuron disease | Asymmetric weakness without sensory loss | May have upper motor neuron signs and cognitive involvement, usually more prominent muscle atrophy | Clinical criteria supported by EMG fndings EDx: active and chronic motor axon loss and fasciculations in multiple regions |
Supportive |
Abbreviations: CIDP, chronic inflammatory demyelinating neuropathy; CSF, cerebrospinal fluid; EDx, electrodiagnostic; EMG, electromyography; IgM, immunoglobulin M; IVIg, intravenous immunoglobulin.